Biotech

All Articles

Merck's LAG-3 combination fails colon cancer phase 3 research

.A try through Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colorectal c...

Spanish VC shuts $200M lifestyle scientific researches fund

.Spain-based Asabys Allies has actually finalized a fund of 180 thousand euros ($ 200 million), mone...

BioAge brings in $198M from IPO as being overweight biotech signs up with Nasdaq

.BioAge Labs is generating nearly $200 thousand through its Nasdaq IPO this morning, along with the ...

Acadia brings BMS vet aboard as chief executive officer-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings and...

Cassava pays $40M over allegedly deceiving Alzheimer's update

.Cassava Sciences has actually agreed to pay $40 million to settle an investigation into insurance c...

Merck bags alternatives on Evaxion's AI-designed injection candidates

.Merck &amp Co. has grabbed choices on 2 Evaxion Biotech injection prospects, paying out $3.2 thousa...

Enanta's RSV antiviral crushes virus-like bunch in challenge research

.Enanta Pharmaceuticals has actually linked its respiratory syncytial virus (RSV) antiviral to signi...

Biogen cans SAGE-324 partnership after crucial trembling fall short

.Biogen has administered the last ceremonies to its own cooperation with Sage Therapies on SAGE-324,...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout ratings

.On the same time that some Parkinson's ailment drugs are actually being actually called into questi...

Arch shuts $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Project Partne...